Management of abnormal semen parameters

Effect of Capsule Vajitone in the management of abnormal semen parameters- A single arm clinical study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/02/049891

Enrollment

Registered

2023-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R37- Sexual dysfunction, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: • Any one or more abnormalities of semen parameters i.e. oligozoospermia ( • Patient with clinical presentation of erectile dysfunction, loss of libido and psychological sexual problem with above abnormal semen parameters

Exclusion criteria

Exclusion criteria: • Age below 21 years and above 45 years of male • Normal all semen parameters i.e. Volume, pH, Autoagglutination, count, motility • Patient of various disease like grade III varicocele, sexually transmitted diseases, uncontrolled DM & HTN and genetic or surgical deformity • Genetic disorders like Klinfelterâ??s syndrome • Only Sertoli cell syndrome • Taking treatment for major psychiatric problem

Design outcomes

Primary

Measure	Time frame
Improvement in oligozoospermia, asthenozoospermia, azoospermiaTimepoint: at baseline, 4 weeks, 8 weeks, 12 weeks	—

Secondary

Measure	Time frame
Improvement in subjective criteria like erectile dysfunctionTimepoint: At baseline, 4 week, 8 week, 12 week	—

Countries

India

Contacts

Public ContactMatangee Pandya

J.S.Ayurveda college

drmatangee144@gmail.com9106241594

Outcome results